What is the therapeutic range for gentamicin in IV therapy?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

What is the therapeutic range for gentamicin in IV therapy?

Gentamicin is an aminoglycoside whose effectiveness depends on achieving a high concentration for a short period (concentration-dependent killing). In IV therapy, the important target is the peak level (Cmax) relative to the pathogen’s MIC, while keeping trough levels low to minimize toxicity. A peak of about 3–5 mg/L is commonly used as a therapeutic target in many IV regimens, especially when using gentamicin for synergy with beta-lactams or for certain infections. Higher peaks (6–8 mg/L or more) increase the risk of nephrotoxicity and ototoxicity without a proportional gain in efficacy, while lower peaks (1–3 mg/L) can be subtherapeutic for pathogens with higher MICs. Therefore, 3–5 mg/L best represents the practical therapeutic peak range for IV gentamicin in many clinical settings.

Gentamicin is an aminoglycoside whose effectiveness depends on achieving a high concentration for a short period (concentration-dependent killing). In IV therapy, the important target is the peak level (Cmax) relative to the pathogen’s MIC, while keeping trough levels low to minimize toxicity. A peak of about 3–5 mg/L is commonly used as a therapeutic target in many IV regimens, especially when using gentamicin for synergy with beta-lactams or for certain infections. Higher peaks (6–8 mg/L or more) increase the risk of nephrotoxicity and ototoxicity without a proportional gain in efficacy, while lower peaks (1–3 mg/L) can be subtherapeutic for pathogens with higher MICs. Therefore, 3–5 mg/L best represents the practical therapeutic peak range for IV gentamicin in many clinical settings.

More practice questions